United Therapeutics director Christopher Patusky reports sale of $701,800 in common shares
UTHR•Christopher Patusky sold 1,210 United Therapeutics common shares at $580 each on November 9, 2026, matching the number of shares he acquired through option exercises that day at $132.30 each.
1. Share transactions
After the transactions, Patusky held 2,140 common shares directly and 1,100 indirectly through a trust. He also held 3,000 directly held stock options.
